Utility of the prostate health index density for detecting clinically significant prostate cancer in patients with negative magnetic resonance imaging findings
The PHI and PHID may serve as valuable adjuncts to MRI for the detection of csPCa and may help avoid unnecessary biopsies in patients with negative MRI findings.
Authors
- Ayako Hayashi (ORCID: https://orcid.org/0000-0001-6278-6318)
- Toshiki Mugita
- Masahiro Kurokawa
- Sho Okada (ORCID: https://orcid.org/0000-0002-1957-2282)
- Yoshiki Tsunokawa (ORCID: https://orcid.org/0000-0002-3567-5839)
- Yoshihiro Nakagami (ORCID: https://orcid.org/0000-0002-3181-2066)
- Kazuhiko Oshinomi (ORCID: https://orcid.org/0000-0003-3129-9079)
- Hiroichi Kishi
- S Kikuchi
- Tatsuki Inoue (ORCID: https://orcid.org/0000-0002-2009-8805)
- Motoki Yamagishi (ORCID: https://orcid.org/0000-0003-4505-7513)
- Takashi Fukagai (ORCID: https://orcid.org/0000-0003-0261-6303)
- Masakazu Nagata
Institutions
- SHOWA Medical University (JP)
Publication Details
- Journal
- Prostate International
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1016/j.prnil.2025.08.004
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00